Latest News in the pharma Industry

All

Vectura signs global development agreement with Dynavax

Vectura signs global development agreement with Dynavax

16 Aug 2017

Agreement convers the clinical application of Vectura's proprietary smart nebuliser technology to deliver Dynavax's investigational immunotherapeutic agent to lung cancer patients.

Read more 
Metacrine collaborates on development of FGF1 variants for glucose lowering and improving insulin sensitivity

Metacrine collaborates on development of FGF1 variants for glucose lowering and improving insulin sensitivity

16 Aug 2017

Novo Nordisk will have an option to license the FGF1 program upon achievement of certain research milestones.

Read more 
Abcam and TTP Labtech collaborate to develop sol-R reagent kits

Abcam and TTP Labtech collaborate to develop sol-R reagent kits

16 Aug 2017

Assay-ready kits will incorporate fully-validated, industry-leading recombinant antibody technology for high throughput research.

Read more 
The Great Hall of China: double digit growth at CPhI China

The Great Hall of China: double digit growth at CPhI China

15 Aug 2017

The Asian pharma event surpasses 55,000 visits with more than 10,000 overseas visits.

Read more 
Bespoke filtration equipment enables pharma manufacturer to fulfil contract

Bespoke filtration equipment enables pharma manufacturer to fulfil contract

15 Aug 2017

Major pharma manufacturer delivers critical drugs to a leading children's hospital.

Read more 
Cambridge Epigenetix and NuGEN Technologies combine leading technologies in epigenetics research

Cambridge Epigenetix and NuGEN Technologies combine leading technologies in epigenetics research

15 Aug 2017

Co-exclusive global licence covers manufacture and integration of CEGX TrueMethyl technology for oxidative bisulfite sequencing with Targeted Methylation and NuGEN Ovation Methyl-Seq systems.

Read more 
Shire submits lifitegrast MAA for treatment of dry eye disease in Europe

Shire submits lifitegrast MAA for treatment of dry eye disease in Europe

15 Aug 2017

Lifitegrast, if approved, would be the first and only new class treatment to address the signs and symptoms of dry eye disease in adults in Europe.

Read more 
Regeneron to discontinue development of suptavumab for respiratory syncytial virus

Regeneron to discontinue development of suptavumab for respiratory syncytial virus

14 Aug 2017

Phase III study fails to meet its primary endpoint.

Read more 
Ionis to go it alone with Inotersen and IONIS-FB-L Rx after GSK decline

Ionis to go it alone with Inotersen and IONIS-FB-L Rx after GSK decline

14 Aug 2017

Inotersen on track for marketing authorization filings this year.

Read more 
Fortress Biotech forms new subsidiary, Aevitas Therapeutics

Fortress Biotech forms new subsidiary, Aevitas Therapeutics

14 Aug 2017

Subsidiary to develop novel AAV gene therapy treatments for complement-mediated.

Read more 
Kalytera submits Phase II study protocol to IRBs for cannabidiol in the prevention of GvHD

Kalytera submits Phase II study protocol to IRBs for cannabidiol in the prevention of GvHD

14 Aug 2017

The Phase II study is designed to generate the pharmacokinetic and safety data, at multiple dose levels, that will be required by the FDA.

Read more 
Tyme Technologies announces the issuance of two new platform patents

Tyme Technologies announces the issuance of two new platform patents

14 Aug 2017

The two patents represent the next generation of SM-88, joining tyrosine and melanin into a potentially more potent combination.

Read more